Current Locations:Home > PRODUCTS > IBI303

IBI303-A Fully Human Monoclonal Antibody Against TNF-α

Indicated for the treatment of autoimmune diseases, covering over 17 indications of rheumatoid arthritis (RA), psoriatic arthritis (PS) and Crohn’s diseases etc; the incidence of RA in China is approximately 0.35% and around 70% of untreated patients end up with a shortened lifespan and disability. IBI303 tackles these debilitating diseases through targeting TNF-α, which plays a fundamental role in the inflammation process in RA and other autoimmune diseases.

Copyright © 2011- Innovent Biologics, Inc.
Powered by RuiXi